Mr. Speaker, I would like to thank my hon. colleague for her thoughtful and always rigorous questions. I do not think very many members do their homework as well as the hon. member for Saanich—Gulf Islands.
The member raises an excellent point. When the House's Standing Committee on Health studied vaping products in March 2015, virtually all the expert testimony identified the apparent reduced harm to users of nicotine vaping products compared with users of combustible tobacco cigarettes. However, the experts also voiced concern about whether the reduction in harm for smokers justified the risks of introducing new nicotine products to the market.
Most of the testimony we have heard has to do with the policy considerations that we are struggling with about encouraging, in any way, the ingestion of nicotine. However, in terms of the actual epidemiological and health impacts of vaping, I think we need a lot more research and information on that. That is something I am looking forward to receiving in the committee to help us craft the kinds of regulations that we think are necessary for this new product.